Clinical Trial Update: PK Switch Efavirenz to Maraviroc in Patients Initially Suppressed on an Efavirenz-containing Regimen [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating switching from an efavirenz-containing regimen to maraviroc in patients who were initially virologically suppressed, focusing on pharma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Selzentry (Maraviroc)
• Sustiva (efavirenz)

Snippet

Sponsor: St Stephens Aids Trust | Conditions: HIV Infection | Phase 4 | Status: COMPLETED